Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 11 » Issue 1

The lung function profile of once-daily tiotropium and olodaterol via Respimat® is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler® (ENERGITO® study)

Total article views   Abstract views HTML views PDF downloads Totals
22,490 Dovepress* 13,662 3,130+ 2,605 16,792
PubMed Central* 0 5,698 2,449 5,698
Totals 13,662 8,828 5,054 22,490
*Since 3 February 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 2 6

View citations on PubMed Central and Google Scholar